A detailed history of Wolf Group Capital Advisors transactions in Merck & Co., Inc. stock. As of the latest transaction made, Wolf Group Capital Advisors holds 16,832 shares of MRK stock, worth $1.68 Million. This represents 0.82% of its overall portfolio holdings.

Number of Shares
16,832
Previous 18,170 7.36%
Holding current value
$1.68 Million
Previous $2.25 Million 15.03%
% of portfolio
0.82%
Previous 0.91%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 31, 2024

SELL
$111.15 - $128.97 $148,718 - $172,561
-1,338 Reduced 7.36%
16,832 $1.91 Million
Q2 2024

Jul 30, 2024

BUY
$123.8 - $132.96 $165,644 - $177,900
1,338 Added 7.95%
18,170 $2.25 Million
Q4 2023

Jan 22, 2024

BUY
$100.18 - $109.02 $26,748 - $29,108
267 Added 1.61%
16,832 $1.84 Million
Q3 2023

Oct 31, 2023

SELL
$102.95 - $114.33 $27,487 - $30,526
-267 Reduced 1.59%
16,565 $1.71 Million
Q2 2023

Jul 31, 2023

BUY
$108.61 - $118.38 $1.83 Million - $1.99 Million
16,832 New
16,832 $1.94 Million

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $253B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Wolf Group Capital Advisors Portfolio

Follow Wolf Group Capital Advisors and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wolf Group Capital Advisors, based on Form 13F filings with the SEC.

News

Stay updated on Wolf Group Capital Advisors with notifications on news.